Skip to main content
logo
Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
4.845
+0.025 (0.52%)
Nov 9, 2026, 4:00 PM EST - Market closed

Clover Health Investments Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
12.45-85.55-43.01-213.36-339.57-587.76
Depreciation & Amortization
0.610.190.131.511.191.25
Other Amortization
1.51.51.210.0313.72
Gain (Loss) on Sale of Investments
-0.38-0.98-0.014.71-8.950.05
Stock-Based Compensation
54.3103.66114.33140.93164.31163.72
Change in Accounts Receivable
-66.04-65.95-6.554.75-8.03-9.39
Reinsurance Recoverable
------0.1
Change in Accounts Payable
0.881.65-2.624.747.645.31
Change in Insurance Reserves / Liabilities
128.64-3.1519.3-0.291.0836.95
Change in Other Net Operating Assets
5.54-16.752.7316.09-3.0449.24
Other Operating Activities
-2.18-1.55-3.05-11.17-119.2544.68
Operating Cash Flow
135.31-66.9334.85-144.66-203.93-282.33
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.03-2.04-1.56-0.58-4.47-0.72
Cash Acquisitions
-----16.45-
Investment in Securities
-39.946.122.12140.6116.05-434.72
Investing Cash Flow
-42.974.080.57140.0195.13-435.45

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt Repaid
------30.93
Net Debt Issued (Repaid)
------30.93
Issuance of Common Stock
4.551.810.91.151.4956.55
Repurchases of Common Stock
-18.88-55.2-18.26-6.22-6.36-0.15
Other Financing Activities
------0.09
Financing Cash Flow
-14.33-53.38-17.36-5.07-4.96925.39

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
78.01-116.2418.05-9.72-113.76207.62

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
132.28-68.9833.29-145.25-208.39-283.05
Free Cash Flow Growth
------
Free Cash Flow Margin
4.83%-3.59%2.43%-11.50%-17.38%-20.79%
Free Cash Flow Per Share
0.24-0.140.07-0.30-0.44-0.69
Levered Free Cash Flow
87.48-37.4200.7868.75-21.71-354.93
Unlevered Free Cash Flow
87.48-37.4200.7868.75-20.89-358.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----1.68
Change in Working Capital
69.02-84.212.8625.29-2.3682.01
SEC Filings: 10-K · 10-Q